Leaflet MONTELUKAST AUROBINDO 10mg film-coated tablets

Product code:
W58991005
Quantity:
28
Indicated for:
asthma; allergic rhinitis
Route of administration:
oral
Substance:
montelukast (leukotriene receptor antagonist)
ATC
R03DC03 — Respiratory system | Other systemic drugs for obstructive airway diseases | Leukotriene receptor antagonists
Montelukast is a medication used for the prevention and treatment of asthma, as well as for relieving symptoms of seasonal or perennial allergic rhinitis. It works by blocking leukotriene receptors, which are chemicals involved in inflammation, thereby reducing airway inflammation and constriction.

It is effective in preventing asthma attacks, especially those triggered by exercise or allergens, but it is not suitable for treating acute asthma attacks. Additionally, it helps reduce symptoms such as sneezing, nasal congestion, and itching associated with allergies.

Montelukast is generally well-tolerated but may cause side effects such as headaches, abdominal pain, or, more rarely, mood changes like anxiety or insomnia. Patients should follow the prescribed treatment and avoid stopping the medication without consulting their doctor.

This medication is typically used as an adjunct therapy in combination with other treatments for asthma or allergies.

General data about MONTELUKAST AUROBINDO 10mg

Substance:
montelukast
Date of latest medicines list:
01-02-2023
Product code:
W58991005
Concentration:
10mg
Pharmaceutical form:
film-coated tablets
Quantity:
28
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
APL SWIFT SERVICES (MALTA) LIMITED - MALTA
Holder:
AUROBINDO PHARMA ROMÂNIA SRL - ROMANIA
Number:
10581/2018/04
Shelf life:
2 years

Concentrations available for montelukast

  • 10mg
  • 4mg
  • 4mg/sachet
  • 5mg